company background image
HNL logo

Dr. Hönle XTRA:HNL Stock Report

Last Price

€11.55

Market Cap

€70.0m

7D

-3.8%

1Y

-26.7%

Updated

08 Oct, 2024

Data

Company Financials +

Dr. Hönle AG

XTRA:HNL Stock Report

Market Cap: €70.0m

HNL Stock Overview

Engages in the supply of industrial UV technologies and systems in Germany and internationally.

About the company

HNL fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 79% below our estimate of its fair value
Earnings are forecast to grow 120.69% per year
Trading at good value compared to peers and industry

Risk Analysis

Debt is not well covered by operating cash flow
Does not have a meaningful market cap (€70M)

Dr. Hönle AG Competitors

Varta

XTRA:VAR1

€79.0m

FRIWO

XTRA:CEA

€203.6m

SBF

DB:CY1K

€23.9m

Voltabox

DB:VBX

€25.1m

Price History & Performance

Summary of all time highs, changes and price drops for Dr. Hönle
Historical stock prices
Current Share Price€11.55
52 Week High€20.30
52 Week Low€11.35
Beta1.45
11 Month Change-16.91%
3 Month Change-25.96%
1 Year Change-26.67%
33 Year Change-72.30%
5 Year Change-76.90%
Change since IPO-33.20%

Recent News & Updates

The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Sep 26
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Aug 06
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Jul 02
Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Recent updates

The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Sep 26
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Aug 06
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Jul 02
Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Oct 11
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Aug 07
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 03
Is Dr. Hönle (ETR:HNL) A Risky Investment?

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Nov 03
The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

Sep 29
Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Jul 06
There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Feb 20
Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 15
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 14
Is Dr. Hönle (ETR:HNL) A Risky Investment?

Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

May 30
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

May 17
Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Mar 29
Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

Mar 16
Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Mar 03
We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Feb 20
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Jan 25
Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

Jan 11
Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dec 27
What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 15
Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

Dec 03
Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Shareholder Returns

HNLDE ElectricalDE Market
7D-3.8%4.0%-1.3%
1Y-26.7%84.3%12.9%

Return vs Industry: HNL underperformed the German Electrical industry which returned 84.3% over the past year.

Return vs Market: HNL underperformed the German Market which returned 12.9% over the past year.

Price Volatility

Is HNL's price volatile compared to industry and market?
HNL volatility
HNL Average Weekly Movement5.2%
Electrical Industry Average Movement5.3%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: HNL has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: HNL's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1976573Markus Arendtwww.hoenle.de

Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing.

Dr. Hönle AG Fundamentals Summary

How do Dr. Hönle's earnings and revenue compare to its market cap?
HNL fundamental statistics
Market cap€70.01m
Earnings (TTM)-€5.37m
Revenue (TTM)€98.69m

0.7x

P/S Ratio

-13.0x

P/E Ratio

Is HNL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HNL income statement (TTM)
Revenue€98.69m
Cost of Revenue€28.34m
Gross Profit€70.35m
Other Expenses€75.72m
Earnings-€5.37m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Jan 30, 2025

Earnings per share (EPS)-0.89
Gross Margin71.28%
Net Profit Margin-5.45%
Debt/Equity Ratio56.3%

How did HNL perform over the long term?

See historical performance and comparison